Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest
Accenture has acquired Bionest, a strategy and consulting firm dedicated to addressing complex strategic decisions […]
enGene Appoints Alex Nichols, PhD as President and Chief Operating Officer
enGene, a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal […]
Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer
Cardiff Oncology, a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to […]
iCRYO Announces Partnership with Therapeutic Manufacturer, BTL
iCRYO, the fast-growing recovery and wellness brand that focuses on a series of health-related recovery […]
Poseida Therapeutics Announces Board Change
Poseida Therapeutics, a clinical-stage cell and gene therapy company advancing a new class of treatments […]
Digital Diagnostics and Tamer Healthcare Announce Strategic Partnership in the Kingdom of Saudi Arabia
Digital Diagnostics, maker of IDx-DR, the first-ever FDA-cleared, fully autonomous AI system for the diagnosis […]
20Med Therapeutics and CEPI Sign Agreement to Advance ThermoStable Vaccines Technology
20Med Therapeutics, a leader in non-viral delivery of genetic vaccines using polymeric nanoparticles, and CEPI, […]
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point of need, […]
AviadoBio Announces Appointment of Jeff Goater as Chair of the Board of Directors
AviadoBio, a pioneering, pre-clinical stage gene therapy company focused on developing and delivering transformative medicines […]
Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, as Chief Medical Officer
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and systemic […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more